Portman Square Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,500
Closed -$1.71M 243
2024
Q4
$1.71M Sell
14,500
-1,700
-10% -$198K 0.06% 190
2024
Q3
$1.79M Hold
16,200
0.07% 235
2024
Q2
$1.59M Hold
16,200
0.05% 245
2024
Q1
$1.81M Sell
16,200
-24,500
-60% -$2.64M 0.05% 202
2023
Q4
$4.1M Sell
40,700
-41,900
-51% -$4.16M 0.09% 215
2023
Q3
$7.17M Buy
82,600
+49,900
+153% +$4.51M 0.18% 149
2023
Q2
$3.09M Buy
+32,700
New +$2.76M 0.09% 191

Other funds holding CAH

Portman Square Capital's CAH Position: Q3 2024 in Review

Portman Square Capital sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 7,371 shares — an estimated $771K sold.

Portman Square Capital first reported a position in CAH in Q3 2023 and held it in 3 quarters. The position peaked at $2.95M in Q3 2023. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Portman Square Capital reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
  • Portman Square Capital sold 7,371 Cardinal Health shares in Q3 2024, an estimated $771K.
  • Portman Square Capital first reported a position in Cardinal Health in Q3 2023 and held it in 3 quarters.
  • Portman Square Capital's Cardinal Health position peaked at $2.95M in Q3 2023.
  • 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Portman Square Capital's 13F filing for Q3 2024, filed 16 Oct 2024.